Clinical trials
Withdrawn Phase 3 trials in Hungary
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2022 | 1 |
| 2024 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 2 |
| Novo Nordisk A/S | 2 |
| Bristol-Myers Squibb | 1 |
| Chiesi Farmaceutici S.p.A. | 1 |
| Eli Lilly and Company | 1 |
| Gan and Lee Pharmaceuticals, USA | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| Marinus Pharmaceuticals | 1 |
| Takeda | 1 |
| UCB Pharma | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 2 |
| Bronchopulmonary Dysplasia | 1 |
| Crohn Disease | 1 |
| Diabetes Mellitus | 1 |
| Diabetes Mellitus, Type 1 | 1 |
| Essential Tremor | 1 |
| Hepatitis C | 1 |
| Insulin Resistance | 1 |
| Lupus Erythematosus, Systemic | 1 |
| Multiple Myeloma | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.